Monobactam Antibacterial class drugs

2 results
  • azactam

    (AZTREONAM)
    E.R. Squibb & Sons, L.L.C.
    AZACTAM is indicated for treating infections caused by susceptible Gram-negative bacteria, including urinary tract, lower respiratory tract, septicemia, skin and skin-structure, intra-abdominal, and gynecologic infections. It is also used adjunctively in surgical management of infections. Concurrent therapy with other antimicrobials may be necessary in seriously ill patients.
  • cayston

    (aztreonam)
    Gilead Sciences, Inc.
    CAYSTON® is indicated for improving respiratory symptoms in cystic fibrosis patients with Pseudomonas aeruginosa. It is not established for use in patients under 7, those with FEV1 <25% or >75%, or those colonized with Burkholderia cepacia. It should only be used in confirmed Pseudomonas infections.